- BCIS occurs in 20% of cemented arthroplasties, although only 0.5 - 1.7% of these are Grade 3
- Reported incidence (any grade) by procedure:
- Cemented hip: 15 - 47%
- Cemented knee: 28 - 71%
- Cemented shoulder: 16%
- Uncemented hip: 0 - 22%
- BCIS also occurs in uncemented arthroplasty but is less severe, with no Grade 3 cases reported in uncemented procedures
- ~6x more common in trauma than elective surgery
- Intra-operative mortality 0.05% for THR vs 0.17% for hemiarthroplasty
Bone Cement Implantation Syndrome
Bone Cement Implantation Syndrome
This topic appeared as part of a CRQ on intra-operative cardiac arrest in September 2024.
Resources
- BCIS is a potentially fatal complication of orthopaedic surgery involving pressurised bone cement
| Patients at high risk |
| ASA III or IV |
| Pulmonary hypertension or systemic hypertension |
| Significant cardiac or pulmonary disease |
| Male gender |
| Increasing age |
| Drugs: diuretics, warfarin |
| Osteoporosis or bony metastases |
| Primary lung cancer or lung metastases |
| Hip fracture (trauma) surgery |
- Cardiovascular disease such as atherosclerosis, angina, heart failure or use of ACE-I/β-blockers are not predictive of Grade 2 or 3 BCIS
Theoretical models
- The embolic model describes embolization of medullary contents into the circulation by the presence of expanding cement in the intramedullary space
- Such emboli include air, fat, marrow, cement, bone particles and fibrin/platelet aggregates
- Right atrial aspirates are predominantly fat (cement particles have not been found)
- Raised intramedullary pressure also occurs with uncemented prostheses, explaining BCIS in uncemented arthroplasty
- Osteoporotic bone is more prone to embolisation during canal pressurisation
- Greater embolic load correlates with greater haemodynamic and respiratory compromise
- These contents are embolised to the pulmonary and/or coronary circulations, leading to:
- Mechanical effects of emboli
- Local mediator release increasing PVR
- The multimodal model is used to account for the fact that the degree of embolisation:
- Correlates poorly with the extent of hypoxia and hypotension
- Cannot alone account for all the features of BCIS
- It describes increased complement (C3a and C5a) levels and raised plasma histamine concentrations in response to the methyl-methacrylate cement
- These mediators cause increased PVR, V/Q mismatch, hypoxia, RV failure and cardiogenic shock
- Direct vasodilatation by methyl-methacrylate monomer is unlikely, as plasma concentrations are too low to cause systemic effects
Pathophysiological effects
- The main pathophysiological effects of BCIS are:
- Hypoxia
- Increased PA pressure (increased PVR)
- V/Q mismatch
- Hypotension
- RV dilation occurs
- Causes shifting of interventricular septum into LV
- This reduces LV compliance, LV filling and thus cardiac output
Timing
- Features of BCIS typically occur at the time of bone cementation and prosthesis insertion
- Highest-risk moments for embolisation: reaming, cementation/prosthesis insertion and hip relocation
- It can, however, occur:
- Before cementation e.g. during femoral reaming
- After cementation e.g. during joint reduction and limb tourniquet deflation
Features
- Classically results in a combination of:
- Arterial hypoxaemia
- Cardiovascular disturbance, typically:
- Hypotension
- Raised PVR and resultant reduction in RV ejection fraction
- Also arrhythmias, cardiogenic shock or cardiac arrest
- Loss of consciousness
- Heart rate rises, but other variables (ETCO2, PA pressure, cardiac output) have not been shown to reliably detect BCIS; SBP and SpO2 are the key monitored variables
Classification
| Feature | Grade 1 | Grade 2 | Grade 3 |
| Incidence | ~20% | 3-5% | ~1% |
| SpO2 | <94% | <88% | - |
| Systolic BP fall | >20% | >40% | CV collapse |
| MAP fall | >15% | >30% | CV collapse |
| Loss of consciousness | No | Yes | Cardiac arrest |
| 30-day mortality | 9.3% | 35% | 88% |
| 1-year mortality | 30% | 48% | 94% |
General
- Identify high-risk patients during team brief
- Discuss alternate surgical strategies, e.g. uncemented fixation (lower severity of BCIS) in high-risk patients
- Use of a 'Cement Curfew', which starts at cement mixing and ends when the hip is relocated
- Closed-loop communication between surgeon and anaesthetist during high-risk stages
Anaesthetic
- Euvolaemia; avoid intravascular volume depletion
- Goal-directed fluid therapy reduced Grade 2 BCIS in THR
- Ensure good cardiac output prior to cement insertion with SBP within 20% of pre-operative value
- Increase FiO2 at the time of cementation
- Measure BP every 2.5mins during cement curfew (if no invasive BP monitoring)
- Neuraxial anaesthesia (alone or with GA) is associated with lower BCIS incidence than GA alone
Surgical technique
| Femoral intramedullary canal | Cement-associated |
| Lavage before cementing (High-pressure, high-volume, pulsatile) |
Bone - vacuum cementing technique |
| Depressurising via suction catheter | Retrograde insertion |
| Brushing and drying of canal | Use of low-viscosity cement |
- Third-generation cementing (vacuum mixing, lavage, retrograde insertion, pressurisation with canal decompression/suction) reduces embolic events and cardiorespiratory disturbance, and is preferred
- BCIS is a time-limited phenomenon and therefore treatment is supportive and aggressive
- PA pressures usually normalise within 24hrs
- Secure airway
- Administer 100% oxygen
- Support cardiovascular physiology with:
- Invasive monitoring e.g. arterial line, central line, CO monitoring
- Volume resuscitation e.g. crystalloid bolus to maintain RV preload
- Vasopressors
- Positive inotropy e.g. β1 agonists
- Standard ALS if cardiac arrest
- Consider ECMO for persistent hypoxaemia refractory to standard management